Oscar Health (NYSE:OSCR) Shares Down 9.5% - What's Next?

Key Points

• Oscar Health's stock price fell by 9.5% to $19.03, trading with a volume decline of 44% compared to its average session volume.
• Recent analyst reports have led to downgrades in ratings and lower price targets, with Barclays setting a new target of $11.00.
• Despite a 29% year-over-year revenue increase, Oscar Health reported a **negative EPS** of ($0.89) for the last quarter, just above the analysts' estimates.

Oscar Health, Inc. (NYSE:OSCR - Get Free Report)'s stock price fell 9.5% on Friday . The stock traded as low as $19.10 and last traded at $19.03. 8,072,500 shares traded hands during trading, a decline of 44% from the average session volume of 14,432,736 shares. The stock had previously closed at $21.03.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Baird R W cut shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Zacks Research raised shares of Oscar Health from a "strong sell" rating to a "hold" rating in a research report on Monday. Barclays cut their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 23rd. Robert W. Baird restated a "neutral" rating and set a $14.00 target price (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Finally, UBS Group reaffirmed a "sell" rating and set a $11.00 price target (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Six investment analysts have rated the stock with a Hold rating and six have issued a Sell rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Reduce" and a consensus price target of $13.19.

Oscar Health Stock Performance

The stock has a market capitalization of $4.98 billion, a P/E ratio of -23.77 and a beta of 1.89. The stock has a 50 day moving average of $18.29 and a 200 day moving average of $16.05. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The firm had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm's revenue was up 29.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.20 EPS. Equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Activity at Oscar Health

In other news, insider Mario Schlosser sold 395,000 shares of the firm's stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the transaction, the insider directly owned 501,148 shares of the company's stock, valued at approximately $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 24.39% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Apollon Wealth Management LLC bought a new position in Oscar Health during the third quarter valued at about $231,000. Farther Finance Advisors LLC boosted its position in shares of Oscar Health by 4,420.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company's stock valued at $25,000 after purchasing an additional 1,282 shares during the period. Matauro LLC boosted its position in shares of Oscar Health by 58.7% in the 3rd quarter. Matauro LLC now owns 111,563 shares of the company's stock valued at $2,112,000 after purchasing an additional 41,249 shares during the period. U.S. Capital Wealth Advisors LLC boosted its position in shares of Oscar Health by 140.0% in the 3rd quarter. U.S. Capital Wealth Advisors LLC now owns 54,000 shares of the company's stock valued at $1,022,000 after purchasing an additional 31,500 shares during the period. Finally, Halter Ferguson Financial Inc. boosted its position in shares of Oscar Health by 81.7% in the 3rd quarter. Halter Ferguson Financial Inc. now owns 385,315 shares of the company's stock valued at $7,294,000 after purchasing an additional 173,249 shares during the period. Institutional investors own 75.70% of the company's stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.